Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 7, 2015
Grant Date -
Aug 1, 2013
app pub date -
Aug 13, 2010
filing date -
Aug 13, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A composition for preventing or treating cervical cancer comprising a human papillomavirus plasmodium and an immunity enhancer is provided. A fusion protein including a fusion polypeptide recombined to transform a 3D structure of E6 and E7, which are antigens against types 16 and 18 human papillomavirus (HPV), a signal peptide for secreting the fusion polypeptide outside the cells and an immunity enhancer peptide present in an individual is also provided. The fusion protein may be useful in treating HPV-triggered tumors by inducing an immune response specific to the antigens against the HPV types 16 and 18.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully